
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
Breast Cancer Update
00:00
Is DXD a Second Line Therapy for Lung Cancer?
TDXD could very well become second line therapy and lung cancer, incidentally. Of course, all these agents with the last name of DXD, one issue you have to think a little bit about or a lot about is an ILD. We were asking people how they screened for it in patients on TDXD. You know, is it just asking for a sentence?
Play episode from 56:16
Transcript


